Nissenson Allen R
Division of Nephrology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Semin Dial. 2009 Nov-Dec;22(6):661-4. doi: 10.1111/j.1525-139X.2009.00671.x.
Over one million patients worldwide have end-stage renal disease and require dialysis or kidney transplantation. Despite the availability of these forms of renal replacement therapy for nearly four decades, mortality and morbidity are high and patients often have a poor quality of life. We have developed a human nephron filter (HNF) utilizing bottom-up nanotechnology that would eventually make feasible a continuously functioning, wearable or implantable artificial kidney. The device consists of two membranes operating in series within one device cartridge. The first membrane mimics the function of the glomerulus, using convective transport to generate a plasma ultra filtrate, which contains all solutes approaching the molecular weight of albumin. The second membrane mimics the function of the renal tubules, selectively reclaiming designated solutes to maintain body homeostasis. No dialysis solution is used in this device. The HNF has been computer modeled, and operating 12 hour per day, 7 days per week the HNF provides the equivalent of 30 ml/min glomerular filtration rate (compared to half that amount for conventional thrice-weekly hemodialysis). The HNF system, by eliminating dialysate and utilizing a novel membrane system created through applied nanotechnology, represents a breakthrough in renal replacement therapy based on the functioning of native kidneys. The enhanced solute removal and wearable design should substantially improve patient outcomes and quality of life.
全球有超过100万患者患有终末期肾病,需要透析或肾移植。尽管这些形式的肾脏替代疗法已存在近四十年,但死亡率和发病率仍然很高,患者的生活质量往往很差。我们利用自下而上的纳米技术开发了一种人类肾单位过滤器(HNF),这最终将使持续运行的可穿戴或可植入人工肾脏成为可能。该装置由在一个设备盒中串联运行的两个膜组成。第一个膜模拟肾小球的功能,利用对流传输产生血浆超滤液,其中包含所有接近白蛋白分子量的溶质。第二个膜模拟肾小管的功能,选择性地回收指定的溶质以维持体内平衡。该装置不使用透析液。HNF已通过计算机建模,每天运行12小时,每周运行7天,HNF提供相当于30毫升/分钟的肾小球滤过率(相比之下,传统的每周三次血液透析的滤过率为该数值的一半)。HNF系统通过消除透析液并利用应用纳米技术创建的新型膜系统,代表了基于天然肾脏功能的肾脏替代疗法的一项突破。增强的溶质清除能力和可穿戴设计应能显著改善患者的治疗效果和生活质量。